Climent M A, Pallarés Curto C, Blanco Guerrero R, Seguí Palmer J M, Germà Lluch J R, de Andrés Basauri L, López López J J
Unidad de Oncología Médica, Hospital de la Santa Creu i Sant Pau, Barcelona.
Med Clin (Barc). 1991 Nov 2;97(15):565-8.
Non-Hodgkin's lymphomas (NHL) originated in the otorhinolaryngological (ORL) area are rare diseases and its therapy is poorly established.
The diagnostic features, treatment and outcome based on therapy of 34 NHLs originated in the ORL area and seen in the Oncology Service from the Hospital de la Santa Creu i Sant Pau during a ten year period were reviewed.
The predominant primary localization was the tonsil (17 patients), followed by rhinopharynx (8), massive involvement of Waldeyer's ring (4), and oropharynx, maxillary sinus and larynx in the remaining cases. In 26 patients the diagnosis was high-grade lymphoma. The stage distribution was 8 patients (24%) in stage I, 16 in stage II (47%), 3 in stage III (9%), and 5 in stage IV (16%). The treatment was heterogeneous and consisted in chemotherapy in 29 patients (38%), radiotherapy in 5 (15%) or the combination of both in 16 (47%). Eleven patients relapsed (38%), more commonly those treated with radiotherapy. The specific actuarial survival was 69%.
NHL originated in the ORL area are uncommon neoplastic diseases, with a commonly dramatic response to chemotherapy. This should be the initial therapeutic modality in all cases.
起源于耳鼻咽喉(ORL)区域的非霍奇金淋巴瘤(NHL)是罕见疾病,其治疗方法尚不完善。
回顾了在十年期间,于圣十字圣保罗医院肿瘤服务中心就诊的34例起源于ORL区域的NHL患者的诊断特征、治疗方法及治疗结果。
主要的原发部位是扁桃体(17例患者),其次是鼻咽(8例)、瓦尔代尔环广泛受累(4例),其余病例为口咽、上颌窦和喉。26例患者诊断为高级别淋巴瘤。分期分布为:I期8例(24%),II期16例(47%),III期3例(9%),IV期5例(16%)。治疗方法不一,29例患者(38%)接受化疗,5例(15%)接受放疗,16例(47%)接受放化疗联合治疗。11例患者复发(38%),放疗患者复发更为常见。特定精算生存率为69%。
起源于ORL区域的NHL是罕见的肿瘤性疾病,通常对化疗反应显著。这应是所有病例的初始治疗方式。